Ryuji Ohsawa

This inventor holds 28 USPTO granted patents and 13 published patent applications, plus 9 CIPO patents and 18 EPO patents, primarily in Peptide Vaccines. Top assignee: Oncotherapy Science, Incorporated. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuji Ohsawa. Retrieved from https://idiyas.com/inventor/ryuji-ohsawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 13)

% Patents Active = 85.7

CIPO Patents = 9 (Patent Applications = 12)

EPO Patents = 18 (Patent Applications = 45)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 61(Granted Patents)

Location History:

Kawasaki, JP (2014)
Kanagawa, JP (2013 - 2020)

Company Filing History:

28 out of 150

Oncotherapy Science, Incorporated

patents

Years Active: 2013-2020

Loading Chart...

Areas of Expertise:

Peptide Vaccines

CDCA1

NEIL3

Tumor-Associated Antigens

HJURP

WDRPUH

MELK

Anti-CDH3

FOXM1

TTK

ECT2

C1ORF59

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10711047 - CDCA1 epitope peptides and vaccines containing the same (2020-07-14),

2. 10597431 - NEIL3 peptides and vaccines including the same (2020-03-24),

3. 9975935 - NEIL3 peptides and vaccines including the same (2018-05-22),

4. 9896492 - HJURP peptides and vaccines including the same (2018-02-20),

5. 9745343 - Method of inducing an immune response by administering WDRPUH epitope peptides (2017-08-29),

6. 9675680 - MELK epitope peptides and vaccines containing the same (2017-06-13),

7. 9446106 - NEIL3 peptides and vaccines including the same (2016-09-20),

8. 9403890 - HJURP peptides and vaccines including the same (2016-08-02),

9. 9387238 - CDCA1 epitope peptides and vaccines containing the same (2016-07-12),

10. 9284349 - Peptide vaccines for cancers expressing tumor-associated antigens (2016-03-15),

11. 9193765 - Melk epitope peptides and vaccines containing the same (2015-11-24),

12. 9119800 - HIG2 and URLC10 epitope peptide and vaccines containing the same (2015-09-01),

13. 9115207 - Method of inducing an immune response by administering WDRPUH epitope peptides (2015-08-25),

14. 9067973 - Peptide vaccines for cancers expressing tumor-associated antigens (2015-06-30),

15. 9045557 - NEIL3 peptides and vaccines including the same (2015-06-02),

Title: Ryuji Ohsawa: Pioneering Inventor from Kanagawa

Introduction: Ryuji Ohsawa is a distinguished inventor hailing from Kanagawa, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ohsawa's recent patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: With a career spanning over two decades, Ohsawa has worked with leading research institutions and tech companies to bring his innovative ideas to life. His expertise lies in the areas of clean energy, robotics, and smart home technologies.

Collaborations: Throughout his career, Ohsawa has collaborated with top engineers, scientists, and designers to create cutting-edge solutions that have the potential to revolutionize various industries.

Conclusion: Ryuji Ohsawa's relentless passion for innovation and his commitment to creating a more sustainable future through technology make him a true visionary in the world of inventors.

Profile summary based on public USPTO records.